By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Join Professor John Camm for his discussion on Atrial Fibrillation.
BBC Breakfast News
Patients and network staff talk about their experiences of being involved in clinical research.
Atrial Fibrillation Antiarrhythmic Drugs.
Professor John Camm discusses the two newest antiarrhythmic drugs dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away.
Watch us work.
Now's your chance to watch us work - check out the video below for a snapshot of our bustling team in action.
Characterisation of the Cardiovascular Effects of a Meal: QTcF Assessment and Further Insights into the Physiological Effects
December 4, 2023
Groundbreaking research paper authored by Dr. Georg Ferber, Dr. Dilshat Djumanov, Dr. Ulrike Lorch, Dr. Edward Jackson, Dr. Joao Almeida Melo, Mr. James Rickard, and Dr. Jorg Taubel.